433 related articles for article (PubMed ID: 31068379)
1. Development of immune checkpoint therapy for cancer.
Fritz JM; Lenardo MJ
J Exp Med; 2019 Jun; 216(6):1244-1254. PubMed ID: 31068379
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors win the 2018 Nobel Prize.
Huang PW; Chang JW
Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
[TBL] [Abstract][Full Text] [Related]
3. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
[No Abstract] [Full Text] [Related]
4. Nobel committee honors tumor immunologists.
Rotte A; D'Orazi G; Bhandaru M
J Exp Clin Cancer Res; 2018 Oct; 37(1):262. PubMed ID: 30376854
[TBL] [Abstract][Full Text] [Related]
5. [From the time in the wilderness to the Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo: the Long March of cancer immunotherapy].
Fridman WH; Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):367-373. PubMed ID: 31038116
[No Abstract] [Full Text] [Related]
6. Immune checkpoint blockade therapy: the 2014 Tang Prize in Biopharmaceutical Science.
Chen YS; Shen CR
Biomed J; 2015; 38(1):5-8. PubMed ID: 25673064
[TBL] [Abstract][Full Text] [Related]
7. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
Liu W; Zang X
Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
[TBL] [Abstract][Full Text] [Related]
8. Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer.
Bakacs T; Moss RW; Kleef R; Szasz MA; Anderson CC
Scand J Immunol; 2019 Dec; 90(6):e12821. PubMed ID: 31589347
[TBL] [Abstract][Full Text] [Related]
9. [Immune checkpoint inhibitors. A breakthrough in cancer therapy].
Cárdenas-Oyarzo AM; Bocchieri-Oyarce PA; Méndez-Laport CR; Zolezzi JM; Ríos JA
Rev Med Chil; 2022 Jan; 150(1):93-99. PubMed ID: 35856970
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNAs in immune responses and immunotherapy in cancer.
Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
[TBL] [Abstract][Full Text] [Related]
11. Putting the Immunologic Brakes on Cancer.
Wolchok J
Cell; 2018 Nov; 175(6):1452-1454. PubMed ID: 30500529
[TBL] [Abstract][Full Text] [Related]
12. Translation of cancer immunotherapy from the bench to the bedside.
Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
[TBL] [Abstract][Full Text] [Related]
13. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing.
Li Z; Song W; Rubinstein M; Liu D
J Hematol Oncol; 2018 Dec; 11(1):142. PubMed ID: 30577797
[TBL] [Abstract][Full Text] [Related]
14. A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.
Altmann DM
Immunology; 2018 Nov; 155(3):283-284. PubMed ID: 30320408
[TBL] [Abstract][Full Text] [Related]
15. [IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS (ICPI) AND IMMUNE RELATED ADVERSE EVENTS (IRAE'S)].
Ben Zvi C; Ehrenfeld M; Shoenfeld Y
Harefuah; 2020 Jul; 159(7):508-515. PubMed ID: 32720769
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors.
Kroemer G; Zitvogel L
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33600556
[TBL] [Abstract][Full Text] [Related]
17. Releasing the Brakes on Cancer Immunotherapy.
Littman DR
Cell; 2015 Sep; 162(6):1186-90. PubMed ID: 26359975
[TBL] [Abstract][Full Text] [Related]
18. CAR T Cell Therapy Progress and Challenges for Solid Tumors.
Stern LA; Jonsson VD; Priceman SJ
Cancer Treat Res; 2020; 180():297-326. PubMed ID: 32215875
[TBL] [Abstract][Full Text] [Related]
19. Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy.
Ljunggren HG; Jonsson R; Höglund P
Scand J Immunol; 2018 Dec; 88(6):e12731. PubMed ID: 30485497
[No Abstract] [Full Text] [Related]
20. Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy.
Nüssing S; Trapani JA; Parish IA
Front Immunol; 2020; 11():589641. PubMed ID: 33072137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
